Lineage Cell Therapeutics
LCTX
#8223
Rank
HK$1.25 B
Marketcap
HK$6.65
Share price
1.22%
Change (1 day)
-33.59%
Change (1 year)

EPS for Lineage Cell Therapeutics (LCTX)

EPS in 2023 (TTM): -HK$1.02

According to Lineage Cell Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$1.01. In 2022 the company made an earnings per share (EPS) of -HK$1.17 an increase over its 2021 EPS that were of -HK$2.02.

EPS history for Lineage Cell Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$1.02-12.57%
2022-HK$1.17-42.31%
2021-HK$2.0285.71%
2020-HK$1.09250%
2019-HK$0.31-88.57%
2018-HK$2.72105.88%
2017-HK$1.32-153.13%
2016HK$2.49-154.24%
2015-HK$4.585.36%
2014-HK$4.35-30.86%
2013-HK$6.2988.37%
2012-HK$3.3419.44%
2011-HK$2.8033.33%
2010-HK$2.1068.75%
2009-HK$1.24-5.88%
2008-HK$1.32183.33%
2007-HK$0.47-25%
2006-HK$0.62-27.27%
2005-HK$0.85-38.89%
2004-HK$1.4038.46%
2003-HK$1.01-43.48%
2002-HK$1.79-26.63%
2001-HK$2.44-28.75%
2000-HK$3.42-13.73%
1999-HK$3.96
1997-HK$2.563.13%
1996-HK$2.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$16.94 1,576.92%๐Ÿ‡บ๐Ÿ‡ธ USA